Biomatrica's Pact with SAIC-Frederick to Focus on RNA Sample Prep in Cancer Research

The agreement to develop improved methods of isolating nucleic acids from tumor samples is expected to yield new commercial products for Biomatrica and provide the company with a foothold in the molecular diagnostics market.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.